Reference
Morton C, et al. Apixaban and rivaroxaban anti-Xa level utilization for guidance of administration of andexanet alfa: a case series. Journal of Thrombosis and Thrombolysis 53: 235-239, No. 1, Jan 2022. Available from: URL: http://doi.org/10.1007/s11239-021-02521-4
Rights and permissions
About this article
Cite this article
Andexanet-alfa/apixaban/rivaroxaban. Reactions Weekly 1918, 43 (2022). https://doi.org/10.1007/s40278-022-20500-z
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-022-20500-z